Evidence map›Paper›PMID 30569403›Full record

ArticleJournal of materials science. Materials in medicine2018

Biomimetic porous silk fibroin/biphasic calcium phosphate scaffold for bone tissue regeneration.

Bin Liu, Xiyuan Gao, Zhaozhong Sun, Qingmin Fang, Xiaopeng Geng, Hanli Zhang, Guanglin Wang, Yongfeng Dou, Peng Hu, Kai Zhu and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of materials science. Materials in medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Bin LiuDepartment of Spine Surgery, Affiliated Hospital of Binzhou Medical University, No. 661, Huanghe 2nd Road, Shandong Province, Binzhou City, P. R. China.
Xiyuan GaoDepartment of Spine Surgery, Affiliated Hospital of Binzhou Medical University, No. 661, Huanghe 2nd Road, Shandong Province, Binzhou City, P. R. China.
Zhaozhong SunDepartment of Spine Surgery, Affiliated Hospital of Binzhou Medical University, No. 661, Huanghe 2nd Road, Shandong Province, Binzhou City, P. R. China. lllbbbsz@163.com.ORCID http://orcid.org/0000-0001-9944-6069
Qingmin FangDepartment of Spine Surgery, Affiliated Hospital of Binzhou Medical University, No. 661, Huanghe 2nd Road, Shandong Province, Binzhou City, P. R. China.
Xiaopeng GengDepartment of Spine Surgery, Affiliated Hospital of Binzhou Medical University, No. 661, Huanghe 2nd Road, Shandong Province, Binzhou City, P. R. China.
Hanli ZhangDepartment of Spine Surgery, Affiliated Hospital of Binzhou Medical University, No. 661, Huanghe 2nd Road, Shandong Province, Binzhou City, P. R. China.
Guanglin WangDepartment of Spine Surgery, Affiliated Hospital of Binzhou Medical University, No. 661, Huanghe 2nd Road, Shandong Province, Binzhou City, P. R. China.
Yongfeng DouDepartment of Spine Surgery, Affiliated Hospital of Binzhou Medical University, No. 661, Huanghe 2nd Road, Shandong Province, Binzhou City, P. R. China.
Peng HuDepartment of Spine Surgery, Affiliated Hospital of Binzhou Medical University, No. 661, Huanghe 2nd Road, Shandong Province, Binzhou City, P. R. China.
Kai ZhuDepartment of Spine Surgery, Affiliated Hospital of Binzhou Medical University, No. 661, Huanghe 2nd Road, Shandong Province, Binzhou City, P. R. China.
Dawei WangDepartment of Spine Surgery, Affiliated Hospital of Binzhou Medical University, No. 661, Huanghe 2nd Road, Shandong Province, Binzhou City, P. R. China.
Jianqiang XingDepartment of Spine Surgery, Affiliated Hospital of Binzhou Medical University, No. 661, Huanghe 2nd Road, Shandong Province, Binzhou City, P. R. China.
Dong LiuDepartment of Spine Surgery, Affiliated Hospital of Binzhou Medical University, No. 661, Huanghe 2nd Road, Shandong Province, Binzhou City, P. R. China.
Min ZhangDepartment of Spine Surgery, Affiliated Hospital of Binzhou Medical University, No. 661, Huanghe 2nd Road, Shandong Province, Binzhou City, P. R. China.
Rui LiDepartment of Spine Surgery, Affiliated Hospital of Binzhou Medical University, No. 661, Huanghe 2nd Road, Shandong Province, Binzhou City, P. R. China.
Binzhou Medical University · CN

Funding

National Natural Science Foundation of China 81071450;81371930
6 · The paper itself

Abstract

The purpose of our study is to prepare a biomimetic porous silk fibroin (SF)/biphasic calcium phosphate (BCP) scaffold, and evaluate its performance in bone tissue regeneration. The differences in pore size, porosity, mechanical strength and biocompatibility of four different fibroin-containing scaffolds (0, 20, 40, and 60% SF) were studied in vitro. After inoculation with MC3T3-E1 cells, the ectopic bone formation ability of the SF/BCP bionic scaffold was evaluated in a rat model. The SEM and CT demonstrated that compared with pure BCP group (0% SF), the pore size and porosity of SF/BCP scaffolds were proportional to SF content, of which 40% of SF and 60% of SF groups were more suitable for cell growth. The compressive strength of SF/BCP scaffold was greater than that of the pure BCP scaffold, and showed a trend of first increasing and then decreasing with the increase of SF content, among which 40% of SF group had the maximum compressive strength (40.80 + 0.68) MPa. The SF/BCP scaffold had good biocompatibility, under the electron microscope, the cells can be smoothly attached to and propagated on the scaffold. After loading the osteoblasts, it showed excellent osteogenic capacity in the rat model. The SF/BCP scaffold can highly simulate the micro-environment of natural bone formation and can meet the requirements of tissue engineering. The SF/BCP biomimetic porous scaffold has excellent physical properties and biocompatibility. It can highly simulate the natural bone matrix composition and microenvironment, and can promote the adhesion and proliferation of osteoblasts. The SF/BCP scaffold has good ectopic osteogenesis after loading with osteoblasts, which can meet the requirements of scaffold materials in tissue engineering, and has broad application prospects in clinical application.

Indexed as

BiomimeticsTissue Scaffolds3T3 CellsAcridine OrangeAlkaline PhosphataseAnimalsBiocompatible MaterialsBone RegenerationCell ProliferationFibroinsGene Expression Regulation, EnzymologicHydroxyapatitesMaterials TestingMiceMicroscopy, Electron, ScanningOptical ImagingAcridine OrangeAlkaline PhosphataseBiocompatible MaterialsFibroinshydroxyapatite-beta tricalcium phosphateHydroxyapatites

Identifiers

PMID30569403
OpenAlexW2904891516

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.